PETS PetMed Express Inc.

PetMeds® Hires Christine Chambers as Chief Financial Officer

PetMeds® Hires Christine Chambers as Chief Financial Officer

Seasoned executive brings a wealth of financial leadership to further accelerate the company’s digital transformation.

DELRAY BEACH, Fla., July 18, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS), Your Trusted Pet Health Expert, announces the appointment of Christine Chambers as its Chief Financial Officer, effective on August 3, 2022.

Chambers is an experienced finance professional with extensive knowledge in the digital consumer space, most recently serving as Senior Vice President, CFO and Treasurer of Seattle-based RealNetworks. Prior to that, she was Vice President of Finance at Rosetta Stone. Chambers also has served as Deputy Director, Budget and Planning at the Bill & Melinda Gates Foundation. She earned an MBA from the University of Washington and a bachelor's degree in finance from Loughborough University, UK. She is an Associate Member of the Chartered Global Management Accountants (CGMA).

“We have made a lot of progress over the last several quarters to reinvigorate the iconic PetMeds business,” said Matt Hulett, President and CEO of PedMed Express. “We have invested in people, product, and strategy, including our foray into the pet telemedicine space. Our new leadership team has both digital transformation and scale experience, and the Board and I are thrilled to welcome Christine to the company. She is a seasoned finance professional with extensive experience in digital transformation in public and private companies. We have worked closely together for over 20 years, and I know first-hand that she has the turnaround chops and experience to help PetMeds into its next phase of growth.”

Chambers, who will report to Hulett, succeeds Bruce Rosenbloom, who will work with the company through a transitionary period for several months to ensure a smooth handoff. “The Board and I would like to thank Bruce for his myriad contributions to PetMeds through over 20 years of service to the company,” Hulett added.

“I am beyond happy and grateful for the opportunity to be working with Matt Hulett and the PetMeds team during this exciting period of growth and transformation,” Chambers said. “I look forward to adding to the company’s operational excellence in the realms of finance, budget, planning, governance, and more. And, of course, I am eager to help PetMeds provide the best products and services to millions of pet parents.”

ABOUT PETMEDS

Founded in 1996, PetMed Express is Your Trusted Pet Health Expert, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at .

FORWARD LOOKING STATEMENTS: The statements contained in this press release that are not purely historical are forward-looking statements, including statements regarding PetMeds’ expectations, beliefs, intentions or strategies regarding the future. All forward-looking statements included in this press release are based upon information available to PetMeds as of the date hereof, and PetMeds assumes no obligation to update any such forward-looking statements. Forward-looking statements involve risks and uncertainties, which could cause actual results to differ materially from those projected. These and other risks relating to PetMeds’ business are set forth in PetMeds’ Form 10-K for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission.

MEDIA CONTACT

Mary Eva Tredway

Butin PR

 



EN
18/07/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetMed Express Inc.

 PRESS RELEASE

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Pro...

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited No Stockholder Action Required at this Time DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today confirmed that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments Limited, a Singapore-based investment firm, to acquire all of the outstanding shares of the Company for $4 per share in cash, subject to variou...

 PRESS RELEASE

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets ...

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds’ giftable assortment focuses on products that improve pets’ everyday health, comfort, safety...

 PRESS RELEASE

PetMeds Extends Existing Shareholder Rights Plan

PetMeds Extends Existing Shareholder Rights Plan DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors (the “Board”) has unanimously approved an amendment to the Company’s existing shareholder rights plan (the “Rights Plan”), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms and conditions of the Rights Plan ...

 PRESS RELEASE

PetMed Express, Inc. Announces Preliminary Second Quarter Results and ...

PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq DELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Form 10-Q for the quarter ended September 30, 2025 within the prescribed time period...

 PRESS RELEASE

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as ...

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- , d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced the appointment, effective immediately, of James LaCamp to the Company’s Board of Directors (the “Board”), and effective October 30, Mr. LaCamp will become Chair of the Audit Commit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch